The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
We’re not sure if X Æ A-12 is the name of a child or a new prescription drug, but we can tell you the latest in this week’s drug pricing news.
News May 4, 2020Just Amash up of this week’s drug pricing news! Welcome to the Week In Review.
News Apr 27, 2020A pot of government gold – and the prospect for no-strings-attached profits – is fueling pharma’s interest in vaccines and treatments for COVID-19 after *decades* of disinterest in treating infectious disease.
News Apr 20, 2020Hey there all you cool cats and kittens, hope you are staying healthy at home! Welcome to the Week in Review in prescription drug pricing.
News Apr 13, 2020With promising news on the horizon, we cannot stress this enough – stay home and save lives!
News Apr 6, 2020As COVID-19 severely threatens the diabetes community’s health and finances, more than 60 people with diabetes and Patients For Affordable Drugs penned an open letter demanding lower list prices on insulin. — (P4AD)
News Apr 1, 2020My name is Nancy Geiler and I am a long-time resident of Lemay, MO.
News Mar 30, 2020P4AD founder and cancer patient, David Mitchell, writes about how the growing crisis around COVID-19 brings into stark view America’s broken drug pricing system. — (Patients For Affordable Drugs)
News Mar 24, 2020My name is David Undlin and I am a longtime resident of the Saint Paul, Minnesota area. Before I retired, I worked as a pharmaceutical sales rep for 20 years.
News Mar 23, 2020A recent CBO score estimates that the Prescription Drug Pricing Reduction Act would save nearly $95 billion in the next decade.
